| Miss Karen Nirschl, | |
|
2765 Jefferson Davis Hwy, Suite 209, Stafford, VA 22554-8331 | |
| (540) 720-2261 | |
| Not Available |
| Full Name | Miss Karen Nirschl |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2765 Jefferson Davis Hwy, Stafford, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104226760 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2202007405 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Karen Nirschl, 654 Old Hunt Way, Herndon, VA 20170-3100 Ph: (703) 635-9448 | Miss Karen Nirschl, 2765 Jefferson Davis Hwy, Suite 209, Stafford, VA 22554-8331 Ph: (540) 720-2261 |
News Archive
CCA Industries, Inc. announced today that it has sold its weight loss business, marketed under the Mega-T brand, to a group formed by Casla Partners Capital Fund I, LP.
Citing the lack of clear guidelines for ordering blood transfusions during surgery, Johns Hopkins researchers say a new study confirms there is still wide variation in the use of transfusions and frequent use of transfused blood in patients who don't need it.
Androgen-deprivation therapy (ADT), commonly used to treat prostate cancer, can worsen heart risk factors and may increase the risk of heart attack and/or cardiac death, although the relationship between ADT and heart attack or cardiac death has not been definitively established, according to a science advisory published in Circulation: Journal of the American Heart Association and CA: A Cancer Journal for Clinicians.
GlycoVaxyn AG, a leader in the development of innovative bioconjugate vaccines, and Professor Jean Lee, principal investigator at the Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, announced today that they have received a USD 3.4 million NIH grant to finance preclinical development of a novel Staphylococcus aureus vaccine. S. aureus is a major cause of hospital-based infections.
Current research supports the use of blood-thinners to help acutely ill, hospitalized patients minimize the risk of death from a pulmonary embolism (PE) and its precursor deep vein thrombosis (DVT).
› Verified 3 days ago
Tracy Ann Bannon, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 31 Stafford Ave, Stafford, VA 22554 Phone: 540-658-6000 | |
Mrs. Leslie H Jordan, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 Eustace Rd, Stafford, VA 22554 Phone: 540-658-6190 | |
Mrs. Donna Lynn Bloom, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2765 Jefferson Davis Hwy, Suite 209, Stafford, VA 22554 Phone: 540-720-2261 Fax: 540-720-5660 | |
Kerry Daly Nenni, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2125 Mountain View Rd, Stafford, VA 22556 Phone: 540-658-6790 | |
Carrie Ingalls Szlyk, MPH, MS-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 31 Stafford Ave, Stafford, VA 22554 Phone: 540-658-6000 | |
Khojistha Azizi, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Wood Dr, Stafford, VA 22556 Phone: 570-878-8070 |